Type 1 diabetes

Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results

Pediatr DiabetesPublished Observational extension of a randomised controlled trial

Authors' conclusion

This further evaluation of CGM supports the findings of the preceding RCT that use of CGM improves glycemic control and reduces hypoglycemia in adolescents and young adults with type 1 diabetes. This trial is

Study context

Population
Adolescents and young adults aged 14 to <25 years with suboptimally controlled T1Drandomised in preceding randomized clinical trial (RCT)
Participants
153 adolescents
Comparison
Continuous Glucose Monitoring (CGM) continued vs CGM initiated after blood glucose monitoring (BGM); within-cohort changes
  • CGM-CGMn = 70
  • BGM-CGMn = 70
Methodological detailsobservational extension phase, 26-week extension, No participants discontinued CGM use during the extension phase
  • Observational extension phase
  • 26-week extension
  • No participants discontinued CGM use during the extension phase

Primary result

As reported in the abstract

HbA1c · 52 weeks (CGM-CGM); 26 weeks of CGM use (BGM-CGM)
CGM-CGM: mean hemoglobin A1c (HbA1c) 8.9% ± 0.9% (74 ± 9.8 mmol/mol) at randomization to 8.3% ± 1.3% (67 ± 14.2 mmol/mol) at 52 weeks
p < 0.001
BGM-CGM: mean HbA1c 8.9% ± 1.2% (74 ± 13.1 mmol/mol) before CGM to 8.5% ± 1.3% (69 ± 14.2 mmol/mol) after 26 weeks of CGM
p < 0.001

Further findings

TIR 70-180 mg/dL

BGM-CGM: mean TIR increased from 34% ± 12% to 38% ± 15%
P = 0.01
CGM-CGM: no significant improvement, 38% ± 13% prerandomization to 41% ± 18% at 52 weeks

Median percent time <70 mg/dL

CGM-CGM: 3.0% before randomization to 1.1% at 52 weeks
P < 0.001
BGM-CGM: 3.3% before CGM initiation to 1.2% after 26 weeks of CGM
P < 0.001

Original publication

Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results. Pediatr Diabetes. Published 26 October 2023. doi:10.1155/2023/6718115

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.